| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:52 UTC |
|---|
| Update Date | 2022-03-07 02:52:02 UTC |
|---|
| HMDB ID | HMDB0015587 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Cyproterone |
|---|
| Description | Cyproterone, also known as ciproterona or novo-cyproterone, belongs to the class of organic compounds known as gluco/mineralocorticoids, progestogins and derivatives. These are steroids with a structure based on a hydroxylated prostane moiety. Cyproterone is an extremely weak basic (essentially neutral) compound (based on its pKa). |
|---|
| Structure | [H][C@@]12C[C@]1([H])[C@@]1(C)C(=CC2=O)C(Cl)=C[C@@]2([H])[C@]3([H])CC[C@](O)(C(C)=O)[C@@]3(C)CC[C@]12[H] InChI=1S/C22H27ClO3/c1-11(24)22(26)7-5-14-12-9-18(23)17-10-19(25)13-8-16(13)21(17,3)15(12)4-6-20(14,22)2/h9-10,12-16,26H,4-8H2,1-3H3/t12-,13+,14-,15-,16-,20-,21-,22-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 6-Chlor-delta(6)-1,2-alpha-methylen-17-alpha-hydroxyprogesteron | ChEBI | | Apo-cyproterone | ChEBI | | Ciproterona | ChEBI | | Ciproterone | ChEBI | | Cyproteronum | ChEBI | | Novo-cyproterone | ChEBI | | Ciproterona servycal | Kegg | | 6-Chlor-delta(6)-1,2-a-methylen-17-a-hydroxyprogesteron | Generator | | 6-Chlor-δ(6)-1,2-α-methylen-17-α-hydroxyprogesteron | Generator | | 6-Chlor-δ(6)-1,2-a-methylen-17-a-hydroxyprogesteron | HMDB | | Cyproterone acetate | HMDB | | Cyproterone, 1alpha,2 alpha,9 beta,10 alpha-isomer | HMDB |
|
|---|
| Chemical Formula | C22H27ClO3 |
|---|
| Average Molecular Weight | 374.901 |
|---|
| Monoisotopic Molecular Weight | 374.164872437 |
|---|
| IUPAC Name | (1S,2S,3S,5R,11R,12S,15R,16S)-15-acetyl-9-chloro-15-hydroxy-2,16-dimethylpentacyclo[9.7.0.0²,⁸.0³,⁵.0¹²,¹⁶]octadeca-7,9-dien-6-one |
|---|
| Traditional Name | cyproterone |
|---|
| CAS Registry Number | 2098-66-0 |
|---|
| SMILES | [H][C@@]12C[C@]1([H])[C@@]1(C)C(=CC2=O)C(Cl)=C[C@@]2([H])[C@]3([H])CC[C@](O)(C(C)=O)[C@@]3(C)CC[C@]12[H] |
|---|
| InChI Identifier | InChI=1S/C22H27ClO3/c1-11(24)22(26)7-5-14-12-9-18(23)17-10-19(25)13-8-16(13)21(17,3)15(12)4-6-20(14,22)2/h9-10,12-16,26H,4-8H2,1-3H3/t12-,13+,14-,15-,16-,20-,21-,22-/m0/s1 |
|---|
| InChI Key | DUSHUSLJJMDGTE-ZJPMUUANSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as gluco/mineralocorticoids, progestogins and derivatives. These are steroids with a structure based on a hydroxylated prostane moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Steroids and steroid derivatives |
|---|
| Sub Class | Pregnane steroids |
|---|
| Direct Parent | Gluco/mineralocorticoids, progestogins and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Progestogin-skeleton
- 20-oxosteroid
- 3-oxosteroid
- 6-halo-steroid
- Halo-steroid
- Hydroxysteroid
- Oxosteroid
- 17-hydroxysteroid
- Cyclohexenone
- Cyclic alcohol
- Alpha-hydroxy ketone
- Tertiary alcohol
- Ketone
- Vinyl halide
- Vinyl chloride
- Haloalkene
- Chloroalkene
- Organooxygen compound
- Organochloride
- Organohalogen compound
- Hydrocarbon derivative
- Alcohol
- Organic oxygen compound
- Organic oxide
- Carbonyl group
- Aliphatic homopolycyclic compound
|
|---|
| Molecular Framework | Aliphatic homopolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.0066 g/L | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 6.25 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 15.9662 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 0.87 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2779.8 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 358.7 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 206.8 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 185.5 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 262.3 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 684.9 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 696.7 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 82.3 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1278.6 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 491.4 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1608.5 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 413.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 479.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 277.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 423.0 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 17.0 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Cyproterone,1TMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3182.1 | Semi standard non polar | 33892256 | | Cyproterone,1TMS,isomer #2 | CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(O[Si](C)(C)C)=C5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3181.8 | Semi standard non polar | 33892256 | | Cyproterone,1TMS,isomer #3 | C=C(O[Si](C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3076.2 | Semi standard non polar | 33892256 | | Cyproterone,2TMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(O[Si](C)(C)C)=C5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3147.0 | Semi standard non polar | 33892256 | | Cyproterone,2TMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(O[Si](C)(C)C)=C5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3118.7 | Standard non polar | 33892256 | | Cyproterone,2TMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(O[Si](C)(C)C)=C5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3406.2 | Standard polar | 33892256 | | Cyproterone,2TMS,isomer #2 | C=C(O[Si](C)(C)C)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3078.0 | Semi standard non polar | 33892256 | | Cyproterone,2TMS,isomer #2 | C=C(O[Si](C)(C)C)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3062.4 | Standard non polar | 33892256 | | Cyproterone,2TMS,isomer #2 | C=C(O[Si](C)(C)C)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3498.1 | Standard polar | 33892256 | | Cyproterone,2TMS,isomer #3 | C=C(O[Si](C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(O[Si](C)(C)C)=C5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3021.8 | Semi standard non polar | 33892256 | | Cyproterone,2TMS,isomer #3 | C=C(O[Si](C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(O[Si](C)(C)C)=C5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3065.7 | Standard non polar | 33892256 | | Cyproterone,2TMS,isomer #3 | C=C(O[Si](C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(O[Si](C)(C)C)=C5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3545.0 | Standard polar | 33892256 | | Cyproterone,3TMS,isomer #1 | C=C(O[Si](C)(C)C)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(O[Si](C)(C)C)=C5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3027.1 | Semi standard non polar | 33892256 | | Cyproterone,3TMS,isomer #1 | C=C(O[Si](C)(C)C)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(O[Si](C)(C)C)=C5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3121.9 | Standard non polar | 33892256 | | Cyproterone,3TMS,isomer #1 | C=C(O[Si](C)(C)C)[C@@]1(O[Si](C)(C)C)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(O[Si](C)(C)C)=C5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3470.0 | Standard polar | 33892256 | | Cyproterone,1TBDMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3448.9 | Semi standard non polar | 33892256 | | Cyproterone,1TBDMS,isomer #2 | CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(O[Si](C)(C)C(C)(C)C)=C5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3420.6 | Semi standard non polar | 33892256 | | Cyproterone,1TBDMS,isomer #3 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3328.4 | Semi standard non polar | 33892256 | | Cyproterone,2TBDMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(O[Si](C)(C)C(C)(C)C)=C5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3634.0 | Semi standard non polar | 33892256 | | Cyproterone,2TBDMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(O[Si](C)(C)C(C)(C)C)=C5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3593.2 | Standard non polar | 33892256 | | Cyproterone,2TBDMS,isomer #1 | CC(=O)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(O[Si](C)(C)C(C)(C)C)=C5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3619.4 | Standard polar | 33892256 | | Cyproterone,2TBDMS,isomer #2 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3591.0 | Semi standard non polar | 33892256 | | Cyproterone,2TBDMS,isomer #2 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3544.8 | Standard non polar | 33892256 | | Cyproterone,2TBDMS,isomer #2 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3690.4 | Standard polar | 33892256 | | Cyproterone,2TBDMS,isomer #3 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(O[Si](C)(C)C(C)(C)C)=C5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3493.3 | Semi standard non polar | 33892256 | | Cyproterone,2TBDMS,isomer #3 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(O[Si](C)(C)C(C)(C)C)=C5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3517.1 | Standard non polar | 33892256 | | Cyproterone,2TBDMS,isomer #3 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(O[Si](C)(C)C(C)(C)C)=C5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3757.5 | Standard polar | 33892256 | | Cyproterone,3TBDMS,isomer #1 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(O[Si](C)(C)C(C)(C)C)=C5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3732.1 | Semi standard non polar | 33892256 | | Cyproterone,3TBDMS,isomer #1 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(O[Si](C)(C)C(C)(C)C)=C5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3730.5 | Standard non polar | 33892256 | | Cyproterone,3TBDMS,isomer #1 | C=C(O[Si](C)(C)C(C)(C)C)[C@@]1(O[Si](C)(C)C(C)(C)C)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(O[Si](C)(C)C(C)(C)C)=C5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C | 3716.6 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Cyproterone GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-8169000000-e02863f674ce9b2cd8af | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Cyproterone GC-MS (1 TMS) - 70eV, Positive | splash10-000x-8206900000-f9ad399212ec8f93d7a6 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Cyproterone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Cyproterone GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Cyproterone 10V, Positive-QTOF | splash10-004i-0009000000-5c9997dd704debdab5ca | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cyproterone 20V, Positive-QTOF | splash10-004i-0009000000-e47fd3a55c3a12221dd5 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cyproterone 40V, Positive-QTOF | splash10-01t9-0791000000-039d99fb2a68dd3679cd | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cyproterone 30V, Positive-QTOF | splash10-004i-0597000000-a25d388400f2d217a3fd | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cyproterone 20V, Negative-QTOF | splash10-00dj-0009000000-537af4c0d2592f4389fd | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cyproterone 10V, Negative-QTOF | splash10-00di-0009000000-bb0aa272579ae3c1410f | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cyproterone 50V, Positive-QTOF | splash10-01sl-0960000000-1c9079a8f9c425570114 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cyproterone 50V, Positive-QTOF | splash10-01sl-0960000000-cfffb9275cd265ceda38 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cyproterone 20V, Positive-QTOF | splash10-004i-0009000000-def96e1d98e700f1f8e5 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cyproterone 30V, Positive-QTOF | splash10-004i-0497000000-0fc287e4bba295d3133f | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cyproterone 40V, Positive-QTOF | splash10-01t9-0791000000-3adc56165c0ed068e6d4 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cyproterone 10V, Positive-QTOF | splash10-004i-0009000000-db09659a5c3f6e2f3fe2 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cyproterone 20V, Positive-QTOF | splash10-0570-0149000000-c48ae0dca71891c801fe | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cyproterone 40V, Positive-QTOF | splash10-00ku-5190000000-499aae6f81444f0a43b8 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cyproterone 10V, Negative-QTOF | splash10-00di-0009000000-e97a51829845bb3ec8ba | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cyproterone 20V, Negative-QTOF | splash10-00e9-0009000000-f19f24879c0b4fb2bfb4 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cyproterone 40V, Negative-QTOF | splash10-0aos-0159000000-749c9046181d23da6e9e | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cyproterone 10V, Positive-QTOF | splash10-056r-0009000000-473b61a34f936d1e6597 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cyproterone 20V, Positive-QTOF | splash10-0550-0149000000-d743c7bd774552b0fafd | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cyproterone 40V, Positive-QTOF | splash10-0080-5291000000-e21e7e39ebcfd99de937 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cyproterone 10V, Negative-QTOF | splash10-00di-0009000000-3fb88b233fdbbb8c9838 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cyproterone 20V, Negative-QTOF | splash10-00di-0009000000-5a882a4f198cfad8fba9 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cyproterone 40V, Negative-QTOF | splash10-00ai-3009000000-e1e5a78c72aa7b9a9504 | 2021-10-11 | Wishart Lab | View Spectrum |
|
|---|
| General References | - Stadtler FA, Langner V: The effect of cyproterone and gonadotrophins on the adrenal gland of juvenile and adult rats. A morphological and morphometrical study. Pathol Res Pract. 1985 Mar;179(4-5):493-8. [PubMed:4001026 ]
- Giorgi EP, Shirley IM, Grant JK, Stewart JC: Androgen dynamics in vitro in the human prostate gland. Effect of cyproterone and cyproterone acetate. Biochem J. 1973 Mar;132(3):465-74. [PubMed:4125095 ]
- Holdaway IM, Croxson MS, Evans MC, France J, Sheehan A, Wilson T, Ibbertson HK: Effect of cyproterone acetate on glucocorticoid secretion in patients treated for hirsutism. Acta Endocrinol (Copenh). 1983 Oct;104(2):222-6. [PubMed:6227191 ]
- Pham-Huu-Trung MT, de Smitter N, Bogyo A, Girard F: Effects of cyproterone acetate on adrenal steroidogenesis in vitro. Horm Res. 1984;20(2):108-15. [PubMed:6237971 ]
- Honer C, Nam K, Fink C, Marshall P, Ksander G, Chatelain RE, Cornell W, Steele R, Schweitzer R, Schumacher C: Glucocorticoid receptor antagonism by cyproterone acetate and RU486. Mol Pharmacol. 2003 May;63(5):1012-20. [PubMed:12695529 ]
- Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
- Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
- Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
- Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
- Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.
|
|---|